Exhibit 11.1(a)
Renal Treatment Centers, Inc. and Subsidiaries
COMPUTATION OF PRIMARY AND FULLY DILUTED EARNINGS PER SHARE
for the quarter ended March 31, 1996
Three Months Ended
March 31, 1996
Primary Fully Diluted
- ----------------------------------------------------------------------------------------
Net income $3,158,054 $3,158,054
Add back interest on note, tax effected -- 67,665
- ----------------------------------------------------------------------------------------
Net income available to common stockholders $3,158,054 $3,225,719
========================================================================================
Weighted average number of shares outstanding 23,554,165 23,554,165
Weighted average number of maximum shares subject
to exercise under outstanding stock options 1,349,743 1,349,743
Weighted average shares assumed issued upon conversion
of note -- 661,501
- ----------------------------------------------------------------------------------------
24,903,908 25,565,409
Less treasury shares assumed purchased with proceeds
from assumed exercise of outstanding common stock
options 625,473 583,641
- ----------------------------------------------------------------------------------------
Weighted average number of common and common stock 24,278,435 24,981,768
equivalents outstanding
========================================================================================
Net income per common and common stock equivalent $0.13 $0.13
========================================================================================
Exhibit 11.1
Renal Treatment Centers, Inc. and Subsidiaries
COMPUTATION OF PRIMARY AND FULLY DILUTED EARNINGS PER SHARE
for the quarter ended March 31, 1995
Three Months Ended
March 31, 1995
Primary Fully Diluted
- ----------------------------------------------------------------------------------------
Net income $2,033,169 $2,033,169
Add back interest on note, tax effected -- 74,357
- ----------------------------------------------------------------------------------------
Net income available to common stockholders $2,033,169 $2,107,526
========================================================================================
Weighted average number of shares outstanding 21,098,552 21,098,552
Weighted average number of maximum share subject
to exercise under outstanding stock options 1,168,198 1,168,198
Weighted average shares assumed issued upon conversion
of note -- 712,024
- ----------------------------------------------------------------------------------------
22,266,750 22,978,774
Less treasury shares assumed purchased with proceeds
from assumed exercise of outstanding common stock
options 735,150 651,854
- ----------------------------------------------------------------------------------------
Weighted average number of common and common stock 21,531,600 22,326,920
equivalents outstanding
========================================================================================
Net income per common and common stock equivalent $0.09 $0.09
========================================================================================